AstraZeneca

AstraZeneca cuts hundreds of jobs in US

Friday, October 7, 2011 02:46 PM

AstraZeneca will streamline portions of its U.S. commercial business as part of the company's strategy to operate its business more effectively and efficiently to best serve patients in the United States. The changes will enable the company to compete in a challenging environment, including pricing pressures and the continuing growth of generic medicines.

More... »

AstraZenca seeks partners in China

Friday, September 23, 2011 02:28 PM

AstraZeneca will continue its cooperation model on research and development (R&D) in China instead of merger and acquisition (M&A), the company's executive said, according to China Daily.

More... »

Trizzino joins Immunovaccine as CEO

Monday, September 12, 2011 12:44 PM

Immunovaccine has named John J. Trizzino chief executive officer, effective October 1, 2011. Trizzino will also be appointed to the company's board of directors.

More... »

Palatin, AstraZenca collaborate in AZD2820 obesity trial

Tuesday, August 16, 2011 10:09 AM

Palatin Technologies and AstraZeneca have initiated the phase I clinical trial of AZD2820, a subcutaneously-administered peptide melanocortin receptor partial agonist, under development as a single-agent therapy for the treatment of obesity.

More... »

Delta Point names Murphy executive account director

Wednesday, July 13, 2011 10:23 AM

Delta Point has named Matt Murphy executive account director.

More... »

AstraZeneca, PTC collaborate in oncology

Thursday, June 30, 2011 09:59 AM

AstraZeneca and PTC Therapeutics are joining forces for cancer cures, using PTC's discovery/development technology platform, reported FierceBiotech.  AZ will front an undisclosed amount of cash to work on the first oncology target.

More... »

AstraZeneca could be eyeing Cubist

Monday, May 23, 2011 02:16 PM

Speculation late last week suggested AstraZeneca could be eyeing an acquisition of Cubist Pharmaceuticals, according to a report in The Telegraph.

More... »

Bayer CEO considers merger only if stars are aligned

Thursday, May 5, 2011 12:40 PM

German-based Bayer is open to a “merger of equals” that would enhance its health-care unit without paying a premium for an acquisition, says Bayer’s chief executive officer Marijn Dekkers, according to a Bloomberg report.

More... »

AstraZeneca will demolish research labs in Delaware

Monday, April 25, 2011 01:30 PM

AstraZeneca will tear down three research laboratory buildings at its headquarters in Fairfax, Delaware, as part of its global restructuring, according to delaware online.

More... »

Report: Some sponsors more prepared to lead the way in personalized medicine than others

Monday, April 18, 2011 08:05 AM

As the pharmaceutical industry’s investment in personalized medicine leads to development of an increasing number of targeted therapies, particularly for cancer patients, some drug sponsors have shown greater commitment and more structure in their approach than others, according to a new report by consulting firm Diaceutics.

More... »